Early studies showed that CD44+/CD24− cells were enriched in the bulk cell population and mammospheres were elevated following neoadjuvant chemotherapy in isolated tumor cells, regardless of receptor subtype [94]. The gene discussed is CD44; the disease is neoplasm.